Latest news
25 items- SECSEC Form 15-12G filed by Histogen Inc.15-12G - Histogen Inc. (0001383701) (Filer)
- SECSEC Form DEFA14A filed by Histogen Inc.DEFA14A - Histogen Inc. (0001383701) (Filer)
- SECSEC Form 425 filed by Histogen Inc.425 - Histogen Inc. (0001383701) (Subject)
- SECHistogen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Histogen Inc. (0001383701) (Filer)
- PRHistogen Announces Second Adjournment of Special Meeting of StockholdersMeeting Adjourned for a Final Time to January 4, 2024 at 8:00 a.m. PTPotential Estimated Cash Distribution to Shareholders of $0.30 to $0.41 if Dissolution Proposal Approved SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (OTC:HSTO), today announced that its special meeting of stockholders (the "Special Meeting") has been adjourned to Thursday, January 4, 2024 at 8:00 a.m. Pacific Time with respect to both proposals described in its definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on October 18, 2023 (the "Proxy Statement"). The Special Meeting, which will be reconvened for a final time on January 4, 2024, will continue to be held v
- SECSEC Form 425 filed by Histogen Inc.425 - Histogen Inc. (0001383701) (Subject)
- SECHistogen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Histogen Inc. (0001383701) (Filer)
- PRHistogen Announces Adjournment of Special Meeting of StockholdersSAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (OTC:HSTO) today announced that its special meeting of stockholders (the "Special Meeting") has been adjourned to Thursday, December 14, 2023 at 8:00 a.m. Pacific Time with respect to both proposals described in its definitive proxy statement filed with the U.S. Securities and Exchange Commission (the "SEC") on October 18, 2023 (the "Proxy Statement"). The reconvened Special Meeting on December 14, 2023 will continue to be held via live webcast at www.virtualshareholdermeeting.com/HSTO2023SM. In addition, the record date for determining stockholders entitled to vote at the Special Meeting will remain the close of business on Octob
- SECSEC Form S-8 POS filed by Histogen Inc.S-8 POS - Histogen Inc. (0001383701) (Filer)
- SECSEC Form S-8 POS filed by Histogen Inc.S-8 POS - Histogen Inc. (0001383701) (Filer)
- SECSEC Form S-8 POS filed by Histogen Inc.S-8 POS - Histogen Inc. (0001383701) (Filer)
- SECSEC Form S-8 POS filed by Histogen Inc.S-8 POS - Histogen Inc. (0001383701) (Filer)
- SECSEC Form 10-Q filed by Histogen Inc.10-Q - Histogen Inc. (0001383701) (Filer)
- SECSEC Form DEF 14A filed by Histogen Inc.DEF 14A - Histogen Inc. (0001383701) (Filer)
- SECSEC Form 25-NSE filed by Histogen Inc.25-NSE - Histogen Inc. (0001383701) (Subject)
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Orchard Therapeutics (NASDAQ:ORTX) shares increased by 96.5% to $15.99 during Thursday's regular session. As of 13:31 EST, Orchard Therapeutics's stock is trading at a volume of 7.9 million, which is 17105.9% of its average full-day volume over the last 100 days. The company's market cap stands at $363.4 million. Histogen (NASDAQ:HSTO) shares moved upwards by 47.17% to $0.75. Trading volume for Histogen's stock is 414.2K as of 13:31 EST. This is 163.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.1 million. Clene (NASDAQ:CLNN) stock moved upwards by 21.0% to $0.6. Trading volume for this security as of 13:31 EST is 2.1 million, which
- SECSEC Form PRE 14A filed by Histogen Inc.PRE 14A - Histogen Inc. (0001383701) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 105.4% to $0.38 during Wednesday's regular session. The current volume of 201.6 million shares is 13196.4% of Vivos Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $11.3 million. Nuvalent (NASDAQ:NUVL) shares moved upwards by 31.37% to $55.73. Trading volume for this security as of 13:30 EST is 3.9 million, which is 1095.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.1 billion. Histogen (NASDAQ:HSTO) stock moved upwards by 27.11% to $0.65. Histogen's stock is trading a
- NEWSWhy Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Gaucho Group Holdings, Inc. (NASDAQ:VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively. Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares climbed 73.6% to $0.3230 after the company announced it executed strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers. Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares climbed 39.7% to $6.72. Histogen Inc. (NASDAQ:HSTO) gained 27% to $0.6350. Pixelworks, Inc. (NASDAQ:PXLW) gained 22% to $1.3100 after reporting preliminary revenue r
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers Sonendo (NYSE:SONX) shares increased by 51.4% to $0.48 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 649.4K shares, which is 1654.5 percent of its average volume over the last 100 days. The company's market cap stands at $25.5 million. PureTech Health (NASDAQ:PRTC) stock increased by 17.26% to $23.7. The company's market cap stands at $650.6 million. Phio Pharma (NASDAQ:PHIO) shares moved upwards by 12.83% to $1.67. The market value of their outstanding shares is at $3.7 million. Histogen (NASDAQ:HSTO) shares rose 10.0% to $0.55. Trading volume for this security closed at 50.1K, accounting for 24.1% of its average full-day vol
- SECHistogen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement8-K - Histogen Inc. (0001383701) (Filer)
- SECHistogen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Histogen Inc. (0001383701) (Filer)
- NEWSWhy Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers MSP Recovery, Inc. (NASDAQ:LIFW) shares jumped 104.5% to $0.1916. Digital Transformation Opportunities Corp. (NASDAQ:DTOC) rose 100.7% to $27.50 after dipping 53% on Tuesday. Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 56.4% to $4.8499. Bluejay Diagnostics, last month, announced a $1.59 million registered direct offering of 216,000 shares at $7.365 per share. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) shares gained 50% to $0.8705 after the company announced its Board of Directors has approved a plan of liquidation and dissolution. AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) rose 38% to $0.1478. TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares gained 32.9% to $0.6974
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers MSP Recovery (NASDAQ:LIFW) stock moved upwards by 118.1% to $0.2 during Wednesday's regular session. MSP Recovery's stock is trading at a volume of 436.7 million shares as of 13:30 EST. This is 3233.0% of its average full-day volume over the last 100 days. The company's market cap stands at $67.9 million. Fresh Tracks Therapeutics (NASDAQ:FRTX) shares rose 54.22% to $0.9. The current volume of 9.9 million shares is 1515.7% of Fresh Tracks Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $5.3 million. Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 49.01% to $4.62. Trading volume
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 70.6% to $5.29 during Wednesday's pre-market session. The company's market cap stands at $6.5 million. TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 53.94% to $0.81. The market value of their outstanding shares is at $1.6 million. Fresh Tracks Therapeutics (NASDAQ:FRTX) stock increased by 52.68% to $0.89. The market value of their outstanding shares is at $5.2 million. Histogen (NASDAQ:HSTO) shares increased by 29.93% to $0.51. The market value of their outstanding shares is at $2.1 million. MSP Recovery (NASDAQ:LIFW) shares rose 28.12% to $0.12. The market value of their outstanding shares is at $39.9 milli
HSTO FAQ
7 questionsWhat does Histogen Inc. do?
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs...Where does HSTO stock trade?
Histogen Inc. (HSTO) is listed on NASDAQ.What sector and industry is HSTO in?
Histogen Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Histogen Inc. go public?
Histogen Inc. (HSTO) completed its IPO in 2013.What are analysts saying about HSTO?
Histogen Inc. has had 1 recent analyst action on file. The most recent action was from HC Wainwright & Co.: Buy with a $240.00 price target on 2021-08-30. Recent price targets cluster around $240.00.What companies are similar to HSTO?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare HSTO side-by-side with any of them on Quantisnow.How can I track HSTO on Quantisnow?
Quantisnow aggregates Histogen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HSTO to receive live email and push alerts on every new disclosure.